Corcept Therapeutics Files 8-K
Ticker: CORT · Form: 8-K · Filed: Mar 3, 2025 · CIK: 1088856
Sentiment: neutral
Topics: 8-K, SEC Filing, Regulatory Update
TL;DR
Corcept filed an 8-K, likely routine updates, check for material news.
AI Summary
Corcept Therapeutics Inc. filed an 8-K on March 3, 2025, reporting other events and financial statements/exhibits. The filing does not contain specific details about new events or financial figures within the provided text.
Why It Matters
This filing indicates Corcept Therapeutics is providing updates to the SEC, which could include material information relevant to investors.
Risk Assessment
Risk Level: low — The filing appears to be a standard procedural update without immediate disclosed material events.
Key Numbers
- 000-50679 — Commission File Number (Identifies the company's SEC filing history.)
- 77-0487658 — I.R.S. Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Corcept Therapeutics Inc. (company) — Registrant
- March 3, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- 101 Redwood Shores Parkway, Redwood City, CA 94065 (address) — Principal Executive Offices
FAQ
What specific 'Other Events' are being reported in this 8-K?
The provided text does not specify the details of the 'Other Events' beyond the general reporting category.
What financial statements or exhibits are included with this filing?
The filing indicates that 'Financial Statements and Exhibits' are being provided, but the specific contents are not detailed in the excerpt.
Is this filing related to a material event or a routine update?
Based on the provided text, it appears to be a routine filing reporting 'Other Events' and exhibits, but the absence of specific details prevents a definitive conclusion about materiality.
When was Corcept Therapeutics Incorporated?
The filing indicates Corcept Therapeutics Incorporated is incorporated in Delaware.
What is the principal executive office address for Corcept Therapeutics?
The principal executive offices are located at 101 Redwood Shores Parkway, Redwood City, CA 94065.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 3, 2025 regarding CORCEPT THERAPEUTICS INC (CORT).